Genmab A/S (GMAB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Genmab A/S, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 19.86x | 12.39x | 32.56x | 35.30x | 57.19x | 33.93x |
| P/B Ratio | 3.28x | 2.65x | 4.48x | 7.05x | 7.62x | 8.44x |
| P/S Ratio | 5.14x | 4.51x | 8.60x | 13.27x | 20.09x | 15.96x |
| Profitability | ||||||
| Gross Margin | 91.7% | 95.4% | 98.6% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 33.6% | 31.1% | 32.3% | 43.2% | 35.1% | 62.4% |
| Net Margin | 25.9% | 36.4% | 26.4% | 37.6% | 35.1% | 47.1% |
| EBITDA Margin | 35.5% | 45.0% | 36.1% | 50.6% | 49.7% | 60.9% |
| Liquidity | ||||||
| Current Ratio | 2.02x | 5.25x | 13.34x | 15.48x | 14.50x | 15.00x |
| Quick Ratio | 2.01x | 5.24x | 13.32x | 15.48x | 14.50x | 15.00x |
| Leverage | ||||||
| Debt/Equity | 0.93x | 0.03x | 0.02x | 0.02x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..